Booz Allen Hamilton BAH · NYSE
$85.32 -4.48% (-$4.00)
Summary
76 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 28% a year over the last 3 years.
- It has raised its dividend 10 years in a row and pays out only 35% of profit.
- It holds more cash than debt: $334.0M against $317.0M.
- The share price is below the Bulios Fair Price.
What to watch
- Analysts expect revenue to fall by 5.7% this fiscal year.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.6 USD for 1 USD of yearly profit. Over the last five years it was 27.1 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 9.9% a year over 5 years. Over the last 3 years it grew by 13% a year. For the next fiscal year analysts expect revenue to fall by 5.7%. Earnings per share grew by 28% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 67 USD
- Sales and administration 24 USD
- Taxes and other 2.1 USD
- Net profit 7.1 USD
Net profit, industry median (Consulting Services) 9.1 USD
Out of every 100 USD of revenue, 7.1 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 2.60%
- Paid out of profit
- 35%
- Raised in a row
- 10 years
You receive $2.32 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 12
- Hold 8
- Sell 3
Today's price within the analysts' price targets
The average target of $90.43 is 6.0% above today's price. 52% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Cost Reimbursable Contract 59%
- Time-and-materials Contract 22%
- Fixed-price Contract 19%
By region
- UNITED STATES 100%
Cost Reimbursable Contract brings in 59% of revenue.
Segments in detail